Page 42 - Chumakov News Today : Breaking News, Live Updates & Top Stories | Vimarsana

French cities facing tougher lockdowns Dominic Penna © Eric Gaillard/Reuters People walking on the Promenade des Anglais in Nice amid imminent local restrictions. - Eric Gaillard/Reuters There are multiple French cities which could need to be placed under local lockdown restrictions, the French health minister has said. At least some local measures will be needed in Nice and the surrounding areas amid the rapid spread of coronavirus, Olivier Veran told reporters this morning. Mr Veran said that decisions on the further regulations deemed necessary will be taken today and to...

G7 countries have pledged to more than double aid to support vaccine access for less wealthy countries.

Coronavirus: What's happening in Canada and around the world Saturday The border between Canada and the United States will remain closed to non-essential travel for at least another month due to the COVID-19 pandemic. Social Sharing The Canadian Press · Posted: Feb 20, 2021 10:56 AM ET | Last Updated: February 21 Canada and the United States have agreed to extend restrictions to non-essential travel across their land border until March 21 in an attempt to limit the threat of more contagious variants of the coronavirus.(Jeff Kowalsky/AFP via Getty Images)

The vaccine can help restore the organism’s ‘immune memory’ and boost immunity when it begins to lower in ten to twelve months post-Covid, according to the researcher

Russia registers its 3rd COVID-19 vaccine Russian prime minister says third coronavirus vaccine – CoviVac – got Health Ministry approval for public use H. J. I. / AA 20.02.2021 PANDEMIC Russia registers its 3rd COVID-19 vaccine The vaccine, called CoviVac, was developed by the Chumakov Center for Research and Development of Immunobiological Drugs Foto: Illustration / AA Russia has registered and its Health Ministry approved a third coronavirus vaccine for public use, the country's prime minister announced on Saturday. The vaccine, called CoviVac, was developed by the Chumakov Center for...